1-15 of 15
Authors: L. Morand-Joubert
Sort by
Journal Article
Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West Africa Free
D B Fofana and others
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 11, November 2018, Pages 3143–3147, https://doi.org/10.1093/jac/dky300
Published: 27 July 2018
Journal Article
Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing Free
T Nguyen and others
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 9, September 2018, Pages 2485–2492, https://doi.org/10.1093/jac/dky198
Published: 04 June 2018
Journal Article
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study) Free
S Lambert-Niclot and others
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 8, August 2018, Pages 2147–2151, https://doi.org/10.1093/jac/dky142
Published: 27 April 2018
Journal Article
Prevalence of HIV-1 drug resistance in treated patients with viral load >50Â copies/mL: a 2014 French nationwide study Free
L. Assoumou and others
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 6, June 2017, Pages 1769–1773, https://doi.org/10.1093/jac/dkx042
Published: 25 February 2017
Journal Article
Virological failure of patients on maraviroc-based antiretroviral therapy
Get access
Stéphanie Raymond and others
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 6, June 2015, Pages 1858–1864, https://doi.org/10.1093/jac/dkv026
Published: 19 February 2015
Journal Article
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients
Get access
Slim Fourati and others
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 5, May 2015, Pages 1507–1512, https://doi.org/10.1093/jac/dku535
Published: 03 January 2015
Journal Article
Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapy
Get access
S. Lambert-Niclot and others
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 4, April 2014, Pages 1086–1089, https://doi.org/10.1093/jac/dkt463
Published: 02 December 2013
Journal Article
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001–2011
Get access
Diane Descamps and others
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 11, November 2013, Pages 2626–2631, https://doi.org/10.1093/jac/dkt238
Published: 24 June 2013
Journal Article
Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses
Get access
S. Lambert-Niclot and others
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 6, June 2013, Pages 1237–1242, https://doi.org/10.1093/jac/dkt003
Published: 29 January 2013
Journal Article
HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes
Get access
S. Reigadas and others
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 4, April 2013, Pages 969–972, https://doi.org/10.1093/jac/dks474
Published: 25 November 2012
Journal Article
Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study
Get access
M. A. Valantin and others
Journal of Antimicrobial Chemotherapy, Volume 67, Issue 3, March 2012, Pages 691–695, https://doi.org/10.1093/jac/dkr504
Published: 07 December 2011
Journal Article
Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropism
Get access
Stéphanie Raymond and others
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 9, September 2011, Pages 1972–1975, https://doi.org/10.1093/jac/dkr224
Published: 14 June 2011
Journal Article
Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial)
Get access
Sébastien Gallien and others
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 1, January 2011, Pages 184–191, https://doi.org/10.1093/jac/dkq395
Published: 28 October 2010
Journal Article
Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France
Get access
Diane Descamps and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 12, December 2010, Pages 2620–2627, https://doi.org/10.1093/jac/dkq380
Published: 21 October 2010
Journal Article
Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir
Get access
B. Masquelier and others
Journal of Antimicrobial Chemotherapy, Volume 61, Issue 6, June 2008, Pages 1362–1368, https://doi.org/10.1093/jac/dkn127
Published: 04 April 2008
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals